Escitalopram Export Market Intelligence: India's 231 Suppliers Shipping to 95 Countries — TransData Nexus 2026

Q: Who are the top escitalopram exporters from India?

The top escitalopram exporters from India are: 1. MEDISPRAY LABORATORIES PRIVATE LIMITED — $77.6M (39.4% market share); 2. AUROBINDO PHARMA LTD — $22.5M (11.5% market share); 3. TORRENT PHARMACEUTICALS LTD — $16.6M (8.4% market share); 4. SANDOZ PRIVATE LIMITED — $12.9M (6.6% market share); 5. AUROBINDO PHARMA LIMITED — $11.1M (5.6% market share). Together they account for 71.5% of India's total escitalopram export value.

Q: What is the total export value of escitalopram from India?

The total export value of escitalopram from India is $196.7M USD, recorded across 5,457 shipment transactions from 231 active exporters to 95 destination countries. The average shipment value is $36.1K.

Q: Which countries import escitalopram from India?

India exports escitalopram to 95 countries worldwide. The top importing countries are: MOROCCO (40.9% share, $80.4M), UNITED STATES (23.6% share, $46.5M), AUSTRALIA (4.2% share, $8.3M), CANADA (3.9% share, $7.7M), POLAND (3.5% share, $6.9M). These five markets account for 76.2% of total export value.

Q: What is the HS code for escitalopram exports from India?

The primary HS code for escitalopram exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of escitalopram exports from India?

The average unit price for escitalopram exports from India is $2.25 USD per unit, with prices ranging from $0.00 to $805.19 depending on formulation, packaging, and order volume. The total market is valued at $196.7M across 5,457 shipments.

Q: Which ports handle escitalopram exports from India?

The primary ports for escitalopram exports from India are SAHAR AIR CARGO ACC (INBOM4) (11.9% of shipments), SAHAR AIR (10.2% of shipments), NHAVA SHEVA SEA (INNSA1) (8.6% of shipments), HYDERABAD ICD (6.8% of shipments), DELHI AIR CARGO ACC (INDEL4) (5.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of escitalopram?

India is one of the world's leading exporters of escitalopram due to its large base of 231 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports escitalopram to 95 countries, demonstrating 49% global market coverage.

Q: What certifications do Indian escitalopram exporters need?

Indian escitalopram exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import escitalopram from India?

There are 628 registered buyers importing escitalopram from India, spread across 95 countries. The repeat buyer rate is 68.2%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top escitalopram supplier from India?

MEDISPRAY LABORATORIES PRIVATE LIMITED is the leading escitalopram exporter from India with a market share of 39.4% and total export value of $77.6M across 77 shipments. The top 5 suppliers together control 71.5% of total export value.

Suresh Sormare

Escitalopram

India Pharmaceutical Trade Intelligence

$196.7M231 Suppliers95 CountriesHS 30049099

ExportsIndia → MOROCCO40.9%India → UNITED STATES23.6%

ImportsCANADA → India$5.3M UNITED STATES → India$18.4K

#1 Supplier: MEDISPRAY LABORATORIES #1 Buyer: CIPLA MAROC

Escitalopram Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Escitalopram to the World

Between 2022 and 2026, India exported $196.7M worth of escitalopram across 5,457 verified shipments to 95 countries — covering 49% of world markets in the CNS & Psychiatric segment. The largest destination is MOROCCO (40.9%). MEDISPRAY LABORATORIES PRIVATE LIMITED leads with a 39.4% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Escitalopram export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Escitalopram export data snapshot — $196.7M · 231 exporters · 95 countriesTransData Nexus · Indian Customs Data

Top Escitalopram Exporters from India

231 active exporters · Ranked by export value

View all 231 →

Top Escitalopram Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MEDISPRAY LABORATORIES PRIVATE LIMITED	$77.6M	77	1	39.4%
2	AUROBINDO PHARMA LTD

Top Countries Importing Escitalopram from India

95 destination markets · Ranked by import value

All 95 countries →

Top Countries Importing Escitalopram from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	MOROCCO	$80.4M	40.9%
2	UNITED STATES	$46.5M	23.6%
3	AUSTRALIA	$8.3M	4.2%
4	CANADA	$7.7M	3.9%
5	POLAND	$6.9M	3.5%
6	BRAZIL	$5.9M	3.0%
7	MALTA	$4.3M	2.2%
8	SOUTH AFRICA	$4.1M	2.1%
9	BELGIUM	$4.1M	2.1%
10	FINLAND	$2.2M	1.1%

MOROCCO is India's largest escitalopram export destination, absorbing 40.9% of total exports worth $80.4M. The top 5 importing countries — MOROCCO, UNITED STATES, AUSTRALIA, CANADA, POLAND — together account for 76.2% of India's total escitalopram export value. The remaining 90 destination countries collectively receive the other 23.8%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Escitalopram to India?

8 origin countries · Total import value: $5.3M

India imports escitalopram from 8 countries with a combined import value of $5.3M. The largest supplier is CANADA ($5.3M, 17 shipments), followed by UNITED STATES and MALTA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Escitalopram to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	CANADA	$5.3M	17	99.3%
2	UNITED STATES	$18.4K	40	0.3%
3	MALTA	$9.8K	35	0.2%
4	DENMARK	$4.9K	5	0.1%
5	GERMANY	$2.0K	4	0.0%
6	BRAZIL	$1.8K	4	0.0%
7	UNITED KINGDOM	$1.1K	2	0.0%
8	CYPRUS	$47	5	0.0%

CANADA is the largest supplier of escitalopram to India, accounting for 99.3% of total import value. The top 5 origin countries — CANADA, UNITED STATES, MALTA, DENMARK, GERMANY — together supply 99.9% of India's escitalopram imports. Click any country to see detailed supplier and buyer data for that import corridor.

Escitalopram — Export Intelligence Video

Visual overview of India's escitalopram import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's escitalopram pharmaceutical import and export market — $196.7M in total trade, 231 verified manufacturers, and 95 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Escitalopram

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, escitalopram received initial approval from the FDA for major depressive disorder in August 2002 and for generalized anxiety disorder in December 2003. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for escitalopram, indicating a competitive generic market. Notably, Teva Pharmaceuticals received approval for a generic version in May 2006. The presence of 231 active Indian exporters underscores India's significant role in supplying escitalopram to the U.S. market.

The regulatory pathway for escitalopram in the U.S. involves stringent compliance with FDA standards, including Good Manufacturing Practices (GMP) and bioequivalence studies for generic approvals. As of March 2026, there are no active FDA import alerts specifically targeting escitalopram, facilitating its continued importation from Indian manufacturers.

2EU & UK Regulatory Framework

In the European Union, the European Medicines Agency (EMA) oversees the approval and monitoring of medicinal products, including escitalopram. Marketing authorizations are granted following a centralized procedure, ensuring uniformity across member states. The UK's Medicines and Healthcare products Regulatory Agency (MHRA) continues to regulate escitalopram post-Brexit, adhering to standards comparable to those of the EMA.

Compliance with EU Good Manufacturing Practice (GMP) guidelines is mandatory for manufacturers exporting to these markets. This includes regular inspections and adherence to quality assurance protocols to ensure product safety and efficacy.

3WHO Essential Medicines & Global Standards

Escitalopram is included in the 24th edition of the WHO Model List of Essential Medicines, published in September 2025, highlighting its importance in treating priority health conditions globally. This inclusion underscores the necessity for its availability and affordability across diverse healthcare settings. Manufacturers are expected to comply with international pharmacopoeia standards, such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), to ensure consistent quality.

4India Regulatory Classification

In India, escitalopram is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates its pricing to ensure affordability; however, as of March 2026, escitalopram is not listed under the Drug Price Control Order (DPCO), allowing market-driven pricing. For export purposes, Indian manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national and international regulatory requirements.

5Patent & Exclusivity Status

The primary patent for escitalopram expired on September 14, 2011, following an extension granted to Forest Laboratories. This expiration has led to increased generic competition, with numerous manufacturers entering the market, thereby enhancing accessibility and affordability of the medication globally.

6Recent Industry Developments

In May 2025, the WHO updated its Model List of Essential Medicines, reaffirming escitalopram's inclusion, which emphasizes its continued relevance in global mental health treatment protocols.

In January 2026, the NPPA conducted a review of antidepressant pricing, including escitalopram, to assess market dynamics and ensure fair pricing practices, although no immediate price controls were implemented.

In March 2026, the CDSCO issued updated guidelines for the export of pharmaceutical products, streamlining the NOC process to facilitate smoother international trade for medications like escitalopram.

These developments reflect ongoing efforts by regulatory bodies to balance the need for stringent oversight with the facilitation of global access to essential medications.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Escitalopram

Retail & reference prices across 9 markets vs. India FOB export price of $2.25/unit

Global Price Benchmark for Escitalopram across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.26	USD	According to the FDA's Orange Book, generic versions of Escitalopram are widely available, contributing to competitive pricing.
United Kingdom	$0.13	GBP	The NHS Drug Tariff lists Escitalopram 10 mg tablets, reflecting the standardized pricing within the National Health Service.
Germany	$0.16	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates pharmaceutical pricing, ensuring affordability and accessibility.
Australia

Supply Chain Risk Assessment — Escitalopram

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Escitalopram, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 70% of APIs used in Indian pharmaceutical manufacturing are sourced from China. This dependency exposes the supply chain to significant risks, particularly when disruptions occur in China.

For instance, between 2018 and 2024, China implemented stringent environmental regulations, leading to the shutdown of numerous chemical manufacturing facilities. This resulted in supply shortages and price escalations for critical KSMs and APIs. Such disruptions underscore the vulnerability of India's pharmaceutical supply chain due to its reliance on Chinese imports.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of Escitalopram account for 71.5% of total exports, with MEDISPRAY LABORATORIES PRIVATE LIMITED alone contributing 39.4%. This high supplier concentration poses a significant risk; any operational or financial issues within these key exporters could disrupt the global supply of Escitalopram.

To mitigate such risks, the Indian government introduced the Production Linked Incentive (PLI) scheme in February 2021, aiming to boost domestic production of APIs and KSMs. By November 2024, two new plants were inaugurated under this scheme to manufacture critical molecules like Penicillin G and 6-APA, essential for various antibiotics. While this initiative is a positive step, its impact on reducing supplier concentration in the Escitalopram supply chain remains to be seen.

Access Complete Escitalopram Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 5,457 transactions across 95 markets.

Request Demo View Pricing

Frequently Asked Questions — Escitalopram Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top escitalopram exporters from India?

The leading escitalopram exporters from India are MEDISPRAY LABORATORIES PRIVATE LIMITED, AUROBINDO PHARMA LTD, TORRENT PHARMACEUTICALS LTD, and 12 others. MEDISPRAY LABORATORIES PRIVATE LIMITED leads with 39.4% market share ($77.6M). The top 5 suppliers together control 71.5% of total export value.

What is the total export value of escitalopram from India?

The total export value of escitalopram from India is $196.7M, recorded across 5,457 shipments from 231 active exporters to 95 countries. The average shipment value is $36.1K.

Which countries import escitalopram from India?

India exports escitalopram to 95 countries. The top importing countries are MOROCCO (40.9%), UNITED STATES (23.6%), AUSTRALIA (4.2%), CANADA (3.9%), POLAND (3.5%), which together account for 76.2% of total export value.

What is the HS code for escitalopram exports from India?

The primary HS code for escitalopram exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Escitalopram

Escitalopram

Top Escitalopram Exporters from India

Top Countries Importing Escitalopram from India

Who Supplies Escitalopram to India?

Quick Facts

Related CNS & Psychiatric

Related Analysis

Need Details?

Escitalopram — Export Intelligence Video

Regulatory Landscape — Escitalopram

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Escitalopram

Supply Chain Risk Assessment — Escitalopram

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Escitalopram Trade Intelligence

Frequently Asked Questions — Escitalopram Exports from India

Who are the top escitalopram exporters from India?

What is the total export value of escitalopram from India?

Which countries import escitalopram from India?

What is the HS code for escitalopram exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of escitalopram exports from India?

Which ports handle escitalopram exports from India?

Why is India a leading exporter of escitalopram?

What certifications do Indian escitalopram exporters need?

How many buyers import escitalopram from India?

What is the market share of the top escitalopram exporter from India?

Analysis Methodology